메뉴 건너뛰기




Volumn 71, Issue 1, 2005, Pages 6-7

The European panel on the appropriateness of Crohn's disease therapy

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2 INHIBITOR; INFLIXIMAB; PROTON PUMP INHIBITOR;

EID: 20544455682     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083864     Document Type: Editorial
Times cited : (4)

References (7)
  • 1
    • 2442560241 scopus 로고    scopus 로고
    • Optimizing anti-TNF treatment in inflammatory bowel disease
    • Rutgeerts P, Van Assche G, Vermeire S: Optimizing anti-TNF treatment in inflammatory bowel disease. Gastroenterology 2004;126:1593-1610.
    • (2004) Gastroenterology , vol.126 , pp. 1593-1610
    • Rutgeerts, P.1    Van Assche, G.2    Vermeire, S.3
  • 2
    • 0032565855 scopus 로고    scopus 로고
    • What is appropriate care?
    • Naylor CD: What is appropriate care? N Engl J Med 1998;338:1918-1920.
    • (1998) N Engl J Med , vol.338 , pp. 1918-1920
    • Naylor, C.D.1
  • 6
    • 0842265247 scopus 로고    scopus 로고
    • Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy
    • Dubois RW, Melmed GY, Henning JM, Laine L: Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy. Aliment Pharmacol Ther 2004;19:197-208.
    • (2004) Aliment Pharmacol Ther , vol.19 , pp. 197-208
    • Dubois, R.W.1    Melmed, G.Y.2    Henning, J.M.3    Laine, L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.